-
JAMA
Original Investigation
April 15, 2024
Wayne A.听Ray,聽PhD; Cecilia P.听Chung,聽MD, MPH; C. Michael聽Stein,聽MB, ChB; Walter聽Smalley,聽MD, MPH; Eli聽Zimmerman,聽MD; William D.听Dupont,聽PhD; Adriana M.听Hung,聽MD, MPH; James R.听Daugherty,聽MS; Alyson聽Dickson,聽MA; Katherine T.听Murray,聽MD
is active quiz
JAMA. 2024; 331(18):1565-1575. 10.1001/jama.2024.3867
This cohort study assesses the association of diltiazem with risk of serious bleeding compared with metoprolol in older adults with atrial fibrillation receiving apixaban or rivaroxaban.
-
榴莲视频 Network Open
Original Investigation
Nephrology
November 14, 2023
Jefferson L.听Triozzi,聽MD; Ryan S.听Hsi,聽MD; Guanchao聽Wang,聽MS; Elvis A.听Akwo,聽MD, MS; Lee聽Wheless,聽MD, PhD; Hua-Chang聽Chen,聽PhD; Ran聽Tao,聽PhD; T. Alp聽Ikizler,聽MD; Cassianne聽Robinson-Cohen,聽PhD; Adriana M.听Hung,聽MD, MPH; VA Million Veteran Program
open access
榴莲视频 Netw Open. 2023; 6(11):e2343290. 10.1001/jamanetworkopen.2023.43290
This genetic association study including genome-wide association study summary statistics of US and European adults uses mendelian randomization analysis to examine the association of genetic proxies of thiazide diuretics with the risk of kidney stones.
-
JAMA Internal Medicine
Original Investigation
June 27, 2022
Anurag聽Verma,聽PhD; Jennifer E.听Huffman,聽PhD; Lina聽Gao,聽PhD; Jessica聽Minnier,聽PhD; Wen-Chih聽Wu,聽MD, MPH; Kelly聽Cho,聽PhD, MPH; Yuk-Lam聽Ho,聽MPH; Bryan R.听Gorman,聽PhD; Saiju聽Pyarajan,聽PhD; Nallakkandi聽Rajeevan,聽PhD; Helene聽Garcon,聽MD; Jacob聽Joseph,聽MBBS, MD; John E.听McGeary,聽PhD; Ayako聽Suzuki,聽MD, PhD, MSc; Peter D.听Reaven,聽MD; Emily S.听Wan,聽MD, MPH; Julie A.听Lynch,聽PhD, RN; Jeffrey M.听Petersen,聽MD; James B.听Meigs,聽MD, MPH; Matthew S.听Freiberg,聽MD, MSc; Elise聽Gatsby,聽MPH; Kristine E.听Lynch,聽MS, PhD; Seyedeh Maryam聽Zekavat,聽BS; Pradeep聽Natarajan,聽MD, MMSc; Sharvari聽Dalal,聽MD; Darshana N.听Jhala,聽MD, BMus; Mehrdad聽Arjomandi,聽MD; Robert A.听Bonomo,聽MD; Trevor K.听Thompson; Gita A.听Pathak,聽PhD; Jin J.听Zhou,聽PhD; Curtis J.听Donskey,聽MD; Ravi K.听Madduri,聽MS; Quinn S.听Wells,聽MD, PharmD; Joel聽Gelernter,聽MD; Rose D. L.听Huang,聽MS; Renato聽Polimanti,聽PhD; Kyong-Mi聽Chang,聽MD; Katherine P.听Liao,聽MD, MPH; Philip S.听Tsao,聽PhD; Yan V.听Sun,聽PhD; Peter W. F.听Wilson,聽MD; Christopher J.听O鈥橠onnell,聽MD, MPH; Adriana M.听Hung,聽MD; J. Michael聽Gaziano,聽MD; Richard L.听Hauger,聽MD; Sudha K.听Iyengar,聽PhD; Shiuh-Wen聽Luoh,聽MD, PhD; VA Million Veteran Program COVID-19 Science Initiative
free access
is active quiz
JAMA Intern Med. 2022; 182(8):796-804. 10.1001/jamainternmed.2022.2141
This genetic association study assesses the association of sickle cell trait with prepandemic health conditions in Million Veteran Program participants and assesses the severity and sequelae of COVID-19.
-
JAMA Internal Medicine
Original Investigation
January 28, 2022
Adriana M.听Hung,聽MD, MPH; Shailja C.听Shah,聽MD, MPH; Alexander G.听Bick,聽MD, PhD; Zhihong聽Yu,聽PhD; Hua-Chang聽Chen,聽PhD; Christine M.听Hunt,聽MD, MPH; Frank聽Wendt,聽PhD; Otis聽Wilson,聽BA; Robert A.听Greevy,聽PhD; Cecilia P.听Chung,聽MD, MPH; Ayako聽Suzuki,聽MD, PhD; Yuk-Lam聽Ho,聽BA; Elvis聽Akwo,聽MD, PhD; Renato聽Polimanti,聽PhD, MSc; Jin聽Zhou,聽PhD; Peter聽Reaven,聽MD; Philip S.听Tsao,聽PhD; J. Michael聽Gaziano,聽MD, MPH; Jennifer E.听Huffman,聽PhD; Jacob聽Joseph,聽MD; Shiuh-Wen聽Luoh,聽MD, PhD; Sudha聽Iyengar,聽PhD; Kyong-Mi聽Chang,聽MD; Juan P.听Casas,聽MD; Michael E.听Matheny,聽MD, MS, MPH; Christopher J.听O鈥橠onnell,聽MD, MPH; Kelly聽Cho,聽PhD, MPH; Ran聽Tao,聽PhD; Katalin聽Susztak,聽MD, PhD; Cassianne聽Robinson-Cohen,聽PhD; Sony聽Tuteja,聽PharmD, MS; Edward D.听Siew,聽MD, MSCI; VA Million Veteran Program COVID-19 Science Initiative
free access
is active quiz
JAMA Intern Med. 2022; 182(4):386-395. 10.1001/jamainternmed.2021.8538
This cohort study of US veterans hospitalized with COVID-19 with genetic information and with African ancestry through the VA Million Veteran Program to evaluates the association of APOL1 variations with.acute kidney injury
-
JAMA
Original Investigation
December 21, 2021
Wayne A.听Ray,聽PhD; Cecilia P.听Chung,聽MD, MPH; C. Michael聽Stein,聽MB, ChB; Walter聽Smalley,聽MD, MPH; Eli聽Zimmerman,聽MD; William D.听Dupont,聽PhD; Adriana M.听Hung,聽MD, MPH; James R.听Daugherty,聽MS; Alyson聽Dickson,聽MA; Katherine T.听Murray,聽MD
free access
is active quiz
JAMA. 2021; 326(23):2395-2404. 10.1001/jama.2021.21222
This cohort study assesses major ischemic and hemorrhagic outcomes in Medicare beneficiaries with atrial fibrillation who were treated with rivaroxaban compared with apixaban.
-
JAMA
Original Investigation
September 19, 2019
Christianne L.听Roumie,聽MD, MPH; Jonathan聽Chipman,聽PhD; Jea Young聽Min,聽PharmD, MPH, PhD; Amber J.听Hackstadt,聽PhD; Adriana M.听Hung,聽MD, MPH; Robert A.听Greevy聽Jr,聽PhD; Carlos G.听Grijalva,聽MD, MPH; Tom聽Elasy,聽MD, MPH; Marie R.听Griffin,聽MD, MPH
free access
JAMA. 2019; 322(12):1167-1177. 10.1001/jama.2019.13206
This cohort study uses data from the National Veterans Health Administration, Medicare, Medicaid, and National Death Index to compare major adverse cardiovascular events among patients with diabetes and reduced kidney function who continued treatment with metformin or sulfonylurea.
-
JAMA
Original Investigation
June 11, 2014
Christianne L.听Roumie,聽MD, MPH; Robert A.听Greevy,聽PhD; Carlos G.听Grijalva,聽MD, MPH; Adriana M.听Hung,聽MD, MPH; Xulei聽Liu,聽MD, MS; Harvey J.听Murff,聽MD, MPH; Tom A.听Elasy,聽MD, MPH; Marie R.听Griffin,聽MD, MPH
free access
has multimedia
JAMA. 2014; 311(22):2288-2296. 10.1001/jama.2014.4312
In a retrospective cohort study of veterans with diabetes initially treated with metformin, Roumie and coauthors compared time to acute myocardial infarction, stroke, or death in patients who added insulin or a sulfonylurea.